Detection rate of unknown primary tumour by using somatostatin receptor PET/CT in patients with metastatic neuroendocrine tumours: a meta-analysis.

Sara De DossoGiorgio TregliaMariarosa PascaleAdriana TamburelloPrasanna SanthanamAlexander S KroissRicardo Pereira MestrePiercarlo SalettiLuca Giovanella

Published in: Endocrine (2019)

Somatostatin receptor PET/CT is very useful in detecting CUP-NETs in patients with metastatic disease. More studies on the change of management by using this imaging method in this setting are needed.

Keyphrases

pet ct
positron emission tomography
high resolution
neuroendocrine tumors
loop mediated isothermal amplification
photodynamic therapy